nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCB1—Lisinopril—dilated cardiomyopathy	0.162	0.532	CbGbCtD
Venlafaxine—ABCB1—Spironolactone—dilated cardiomyopathy	0.142	0.468	CbGbCtD
Venlafaxine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0147	0.574	CbGeAlD
Venlafaxine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00794	0.31	CbGeAlD
Venlafaxine—NPY1R—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.00333	0.0634	CbGpPWpGaD
Venlafaxine—Otitis media—Lisinopril—dilated cardiomyopathy	0.00329	0.00533	CcSEcCtD
Venlafaxine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00327	0.0053	CcSEcCtD
Venlafaxine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0032	0.00519	CcSEcCtD
Venlafaxine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00314	0.00508	CcSEcCtD
Venlafaxine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00309	0.005	CcSEcCtD
Venlafaxine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00309	0.005	CcSEcCtD
Venlafaxine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00298	0.00482	CcSEcCtD
Venlafaxine—Mental disability—Furosemide—dilated cardiomyopathy	0.00296	0.0048	CcSEcCtD
Venlafaxine—Breast pain—Lisinopril—dilated cardiomyopathy	0.00294	0.00475	CcSEcCtD
Venlafaxine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00291	0.00472	CcSEcCtD
Venlafaxine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00289	0.00469	CcSEcCtD
Venlafaxine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00287	0.00465	CcSEcCtD
Venlafaxine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00286	0.00463	CcSEcCtD
Venlafaxine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00285	0.00461	CcSEcCtD
Venlafaxine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00284	0.00459	CcSEcCtD
Venlafaxine—Polyuria—Furosemide—dilated cardiomyopathy	0.00282	0.00457	CcSEcCtD
Venlafaxine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00282	0.00456	CcSEcCtD
Venlafaxine—Cough increased—Lisinopril—dilated cardiomyopathy	0.0028	0.00453	CcSEcCtD
Venlafaxine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00278	0.00451	CcSEcCtD
Venlafaxine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00278	0.0045	CcSEcCtD
Venlafaxine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00277	0.00448	CcSEcCtD
Venlafaxine—Deafness—Furosemide—dilated cardiomyopathy	0.00277	0.00448	CcSEcCtD
Venlafaxine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00276	0.00447	CcSEcCtD
Venlafaxine—Gout—Lisinopril—dilated cardiomyopathy	0.00274	0.00444	CcSEcCtD
Venlafaxine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00272	0.00441	CcSEcCtD
Venlafaxine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00269	0.00436	CcSEcCtD
Venlafaxine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00264	0.00427	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00263	0.00425	CcSEcCtD
Venlafaxine—Thirst—Furosemide—dilated cardiomyopathy	0.0026	0.00422	CcSEcCtD
Venlafaxine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00259	0.0042	CcSEcCtD
Venlafaxine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00259	0.0042	CcSEcCtD
Venlafaxine—Purpura—Furosemide—dilated cardiomyopathy	0.00257	0.00416	CcSEcCtD
Venlafaxine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00256	0.00415	CcSEcCtD
Venlafaxine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00256	0.00415	CcSEcCtD
Venlafaxine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00254	0.00412	CcSEcCtD
Venlafaxine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00252	0.00407	CcSEcCtD
Venlafaxine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.0025	0.00405	CcSEcCtD
Venlafaxine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00249	0.00403	CcSEcCtD
Venlafaxine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00249	0.00403	CcSEcCtD
Venlafaxine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00249	0.00403	CcSEcCtD
Venlafaxine—Malaise—Spironolactone—dilated cardiomyopathy	0.00247	0.004	CcSEcCtD
Venlafaxine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00247	0.004	CcSEcCtD
Venlafaxine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00245	0.00398	CcSEcCtD
Venlafaxine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00242	0.00392	CcSEcCtD
Venlafaxine—Photophobia—Lisinopril—dilated cardiomyopathy	0.0024	0.00389	CcSEcCtD
Venlafaxine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0024	0.00389	CcSEcCtD
Venlafaxine—Irritability—Furosemide—dilated cardiomyopathy	0.00236	0.00383	CcSEcCtD
Venlafaxine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00236	0.00381	CcSEcCtD
Venlafaxine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00232	0.00376	CcSEcCtD
Venlafaxine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00232	0.00375	CcSEcCtD
Venlafaxine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00231	0.00374	CcSEcCtD
Venlafaxine—Dehydration—Furosemide—dilated cardiomyopathy	0.0023	0.00373	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00226	0.00366	CcSEcCtD
Venlafaxine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00226	0.00365	CcSEcCtD
Venlafaxine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00225	0.00365	CcSEcCtD
Venlafaxine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00224	0.00363	CcSEcCtD
Venlafaxine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00224	0.00362	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00223	0.00361	CcSEcCtD
Venlafaxine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00223	0.00361	CcSEcCtD
Venlafaxine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00219	0.00355	CcSEcCtD
Venlafaxine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00219	0.00354	CcSEcCtD
Venlafaxine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00216	0.00349	CcSEcCtD
Venlafaxine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00215	0.00348	CcSEcCtD
Venlafaxine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00214	0.00346	CcSEcCtD
Venlafaxine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00212	0.00343	CcSEcCtD
Venlafaxine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0021	0.0034	CcSEcCtD
Venlafaxine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0021	0.0034	CcSEcCtD
Venlafaxine—Eczema—Lisinopril—dilated cardiomyopathy	0.00207	0.00335	CcSEcCtD
Venlafaxine—Injury—Lisinopril—dilated cardiomyopathy	0.00202	0.00328	CcSEcCtD
Venlafaxine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.002	0.00325	CcSEcCtD
Venlafaxine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00199	0.00322	CcSEcCtD
Venlafaxine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00198	0.0032	CcSEcCtD
Venlafaxine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00196	0.00318	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00195	0.00317	CcSEcCtD
Venlafaxine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00195	0.00316	CcSEcCtD
Venlafaxine—NPY1R—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00194	0.0369	CbGpPWpGaD
Venlafaxine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00193	0.00313	CcSEcCtD
Venlafaxine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00191	0.0031	CcSEcCtD
Venlafaxine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.0019	0.00308	CcSEcCtD
Venlafaxine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.0019	0.00307	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00189	0.00307	CcSEcCtD
Venlafaxine—Renal failure—Furosemide—dilated cardiomyopathy	0.00188	0.00304	CcSEcCtD
Venlafaxine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00187	0.00302	CcSEcCtD
Venlafaxine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00186	0.00301	CcSEcCtD
Venlafaxine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00186	0.00301	CcSEcCtD
Venlafaxine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00184	0.00299	CcSEcCtD
Venlafaxine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00184	0.00299	CcSEcCtD
Venlafaxine—Sweating—Furosemide—dilated cardiomyopathy	0.00183	0.00296	CcSEcCtD
Venlafaxine—NPY1R—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0018	0.0343	CbGpPWpGaD
Venlafaxine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00179	0.00291	CcSEcCtD
Venlafaxine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00178	0.00289	CcSEcCtD
Venlafaxine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00178	0.00288	CcSEcCtD
Venlafaxine—Irritability—Lisinopril—dilated cardiomyopathy	0.00177	0.00287	CcSEcCtD
Venlafaxine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00177	0.00287	CcSEcCtD
Venlafaxine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00177	0.00286	CcSEcCtD
Venlafaxine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00175	0.00283	CcSEcCtD
Venlafaxine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00174	0.00282	CcSEcCtD
Venlafaxine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00173	0.0028	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0017	0.0323	CbGpPWpGaD
Venlafaxine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0017	0.00275	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00167	0.00271	CcSEcCtD
Venlafaxine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00167	0.00271	CcSEcCtD
Venlafaxine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00165	0.00267	CcSEcCtD
Venlafaxine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00165	0.00267	CcSEcCtD
Venlafaxine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00165	0.00266	CcSEcCtD
Venlafaxine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00162	0.00262	CcSEcCtD
Venlafaxine—Asthma—Lisinopril—dilated cardiomyopathy	0.00161	0.0026	CcSEcCtD
Venlafaxine—Influenza—Lisinopril—dilated cardiomyopathy	0.00161	0.0026	CcSEcCtD
Venlafaxine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0016	0.00259	CcSEcCtD
Venlafaxine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00159	0.00258	CcSEcCtD
Venlafaxine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00158	0.00256	CcSEcCtD
Venlafaxine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00158	0.00255	CcSEcCtD
Venlafaxine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00157	0.00253	CcSEcCtD
Venlafaxine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00155	0.0025	CcSEcCtD
Venlafaxine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00153	0.00248	CcSEcCtD
Venlafaxine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00153	0.00248	CcSEcCtD
Venlafaxine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00153	0.00247	CcSEcCtD
Venlafaxine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0015	0.00243	CcSEcCtD
Venlafaxine—Dysuria—Lisinopril—dilated cardiomyopathy	0.0015	0.00243	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00149	0.00242	CcSEcCtD
Venlafaxine—Erythema—Furosemide—dilated cardiomyopathy	0.00149	0.00242	CcSEcCtD
Venlafaxine—NPY1R—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00149	0.0284	CbGpPWpGaD
Venlafaxine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00148	0.0024	CcSEcCtD
Venlafaxine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00148	0.0024	CcSEcCtD
Venlafaxine—Flatulence—Furosemide—dilated cardiomyopathy	0.00147	0.00238	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00147	0.00237	CcSEcCtD
Venlafaxine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00146	0.00237	CcSEcCtD
Venlafaxine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00146	0.00237	CcSEcCtD
Venlafaxine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00145	0.00235	CcSEcCtD
Venlafaxine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00145	0.00235	CcSEcCtD
Venlafaxine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00144	0.00233	CcSEcCtD
Venlafaxine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00143	0.00232	CcSEcCtD
Venlafaxine—Depression—Lisinopril—dilated cardiomyopathy	0.00143	0.00231	CcSEcCtD
Venlafaxine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00142	0.0023	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00142	0.0023	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00141	0.00229	CcSEcCtD
Venlafaxine—Rash—Spironolactone—dilated cardiomyopathy	0.00141	0.00229	CcSEcCtD
Venlafaxine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00141	0.00228	CcSEcCtD
Venlafaxine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00141	0.00228	CcSEcCtD
Venlafaxine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00141	0.00228	CcSEcCtD
Venlafaxine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0014	0.00227	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0014	0.00227	CcSEcCtD
Venlafaxine—Headache—Spironolactone—dilated cardiomyopathy	0.0014	0.00227	CcSEcCtD
Venlafaxine—Jaundice—Lisinopril—dilated cardiomyopathy	0.0014	0.00226	CcSEcCtD
Venlafaxine—NPY1R—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00139	0.0264	CbGpPWpGaD
Venlafaxine—Anaemia—Furosemide—dilated cardiomyopathy	0.00138	0.00223	CcSEcCtD
Venlafaxine—Sweating—Lisinopril—dilated cardiomyopathy	0.00137	0.00222	CcSEcCtD
Venlafaxine—Agitation—Furosemide—dilated cardiomyopathy	0.00137	0.00222	CcSEcCtD
Venlafaxine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00137	0.00221	CcSEcCtD
Venlafaxine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00135	0.00219	CcSEcCtD
Venlafaxine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00134	0.00218	CcSEcCtD
Venlafaxine—Vertigo—Furosemide—dilated cardiomyopathy	0.00134	0.00217	CcSEcCtD
Venlafaxine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00134	0.00216	CcSEcCtD
Venlafaxine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00134	0.00216	CcSEcCtD
Venlafaxine—Nausea—Spironolactone—dilated cardiomyopathy	0.00133	0.00215	CcSEcCtD
Venlafaxine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00131	0.00212	CcSEcCtD
Venlafaxine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00209	CcSEcCtD
Venlafaxine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00208	CcSEcCtD
Venlafaxine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00128	0.00207	CcSEcCtD
Venlafaxine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00128	0.00207	CcSEcCtD
Venlafaxine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00124	0.00201	CcSEcCtD
Venlafaxine—Confusional state—Furosemide—dilated cardiomyopathy	0.00123	0.00199	CcSEcCtD
Venlafaxine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00122	0.00197	CcSEcCtD
Venlafaxine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00122	0.00197	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0012	0.0229	CbGpPWpGaD
Venlafaxine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.0012	0.00194	CcSEcCtD
Venlafaxine—Shock—Furosemide—dilated cardiomyopathy	0.0012	0.00194	CcSEcCtD
Venlafaxine—Flushing—Lisinopril—dilated cardiomyopathy	0.00119	0.00193	CcSEcCtD
Venlafaxine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00119	0.00193	CcSEcCtD
Venlafaxine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00118	0.00191	CcSEcCtD
Venlafaxine—Anorexia—Furosemide—dilated cardiomyopathy	0.00116	0.00188	CcSEcCtD
Venlafaxine—Chills—Lisinopril—dilated cardiomyopathy	0.00115	0.00187	CcSEcCtD
Venlafaxine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00115	0.00186	CcSEcCtD
Venlafaxine—Hypotension—Furosemide—dilated cardiomyopathy	0.00114	0.00184	CcSEcCtD
Venlafaxine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00114	0.00184	CcSEcCtD
Venlafaxine—Erythema—Lisinopril—dilated cardiomyopathy	0.00112	0.00181	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00112	0.0213	CbGpPWpGaD
Venlafaxine—Flatulence—Lisinopril—dilated cardiomyopathy	0.0011	0.00179	CcSEcCtD
Venlafaxine—Tension—Lisinopril—dilated cardiomyopathy	0.0011	0.00178	CcSEcCtD
Venlafaxine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0011	0.00178	CcSEcCtD
Venlafaxine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00109	0.00177	CcSEcCtD
Venlafaxine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00109	0.00176	CcSEcCtD
Venlafaxine—Back pain—Lisinopril—dilated cardiomyopathy	0.00108	0.00175	CcSEcCtD
Venlafaxine—Somnolence—Furosemide—dilated cardiomyopathy	0.00108	0.00175	CcSEcCtD
Venlafaxine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00108	0.00174	CcSEcCtD
Venlafaxine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00106	0.00171	CcSEcCtD
Venlafaxine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00106	0.00171	CcSEcCtD
Venlafaxine—Fatigue—Furosemide—dilated cardiomyopathy	0.00105	0.0017	CcSEcCtD
Venlafaxine—Tremor—Lisinopril—dilated cardiomyopathy	0.00105	0.0017	CcSEcCtD
Venlafaxine—Constipation—Furosemide—dilated cardiomyopathy	0.00104	0.00169	CcSEcCtD
Venlafaxine—Pain—Furosemide—dilated cardiomyopathy	0.00104	0.00169	CcSEcCtD
Venlafaxine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00104	0.00168	CcSEcCtD
Venlafaxine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00103	0.00168	CcSEcCtD
Venlafaxine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00102	0.00166	CcSEcCtD
Venlafaxine—Malaise—Lisinopril—dilated cardiomyopathy	0.00101	0.00163	CcSEcCtD
Venlafaxine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00101	0.00163	CcSEcCtD
Venlafaxine—Syncope—Lisinopril—dilated cardiomyopathy	0.001	0.00163	CcSEcCtD
Venlafaxine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.001	0.00162	CcSEcCtD
Venlafaxine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.001	0.00162	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000996	0.00161	CcSEcCtD
Venlafaxine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000989	0.0016	CcSEcCtD
Venlafaxine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000984	0.00159	CcSEcCtD
Venlafaxine—Cough—Lisinopril—dilated cardiomyopathy	0.000977	0.00158	CcSEcCtD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000975	0.0185	CbGpPWpGaD
Venlafaxine—Urticaria—Furosemide—dilated cardiomyopathy	0.000967	0.00157	CcSEcCtD
Venlafaxine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000963	0.00156	CcSEcCtD
Venlafaxine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000963	0.00156	CcSEcCtD
Venlafaxine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000953	0.00154	CcSEcCtD
Venlafaxine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000953	0.00154	CcSEcCtD
Venlafaxine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000953	0.00154	CcSEcCtD
Venlafaxine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00095	0.00154	CcSEcCtD
Venlafaxine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000942	0.00152	CcSEcCtD
Venlafaxine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000932	0.00151	CcSEcCtD
Venlafaxine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000921	0.00149	CcSEcCtD
Venlafaxine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000914	0.00148	CcSEcCtD
Venlafaxine—Oedema—Lisinopril—dilated cardiomyopathy	0.000914	0.00148	CcSEcCtD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000912	0.0173	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000912	0.0173	CbGpPWpGaD
Venlafaxine—Infection—Lisinopril—dilated cardiomyopathy	0.000908	0.00147	CcSEcCtD
Venlafaxine—Shock—Lisinopril—dilated cardiomyopathy	0.000899	0.00146	CcSEcCtD
Venlafaxine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000897	0.00145	CcSEcCtD
Venlafaxine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000895	0.00145	CcSEcCtD
Venlafaxine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000892	0.00144	CcSEcCtD
Venlafaxine—ABCG2—heart—dilated cardiomyopathy	0.000891	0.0347	CbGeAlD
Venlafaxine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000883	0.00143	CcSEcCtD
Venlafaxine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000882	0.0168	CbGpPWpGaD
Venlafaxine—Asthenia—Furosemide—dilated cardiomyopathy	0.000874	0.00141	CcSEcCtD
Venlafaxine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000871	0.00141	CcSEcCtD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000864	0.0164	CbGpPWpGaD
Venlafaxine—Pruritus—Furosemide—dilated cardiomyopathy	0.000862	0.0014	CcSEcCtD
Venlafaxine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000854	0.00138	CcSEcCtD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000848	0.0161	CbGpPWpGaD
Venlafaxine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000833	0.00135	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000832	0.00135	CcSEcCtD
Venlafaxine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000826	0.00134	CcSEcCtD
Venlafaxine—CYP2B6—heart—dilated cardiomyopathy	0.000822	0.032	CbGeAlD
Venlafaxine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00082	0.00133	CcSEcCtD
Venlafaxine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000815	0.00132	CcSEcCtD
Venlafaxine—CYP2C9—heart—dilated cardiomyopathy	0.000814	0.0317	CbGeAlD
Venlafaxine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000812	0.00132	CcSEcCtD
Venlafaxine—Dizziness—Furosemide—dilated cardiomyopathy	0.000805	0.0013	CcSEcCtD
Venlafaxine—SLC6A4—Monoamine Transport—AGT—dilated cardiomyopathy	0.000804	0.0153	CbGpPWpGaD
Venlafaxine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000804	0.0013	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000797	0.0152	CbGpPWpGaD
Venlafaxine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000794	0.00129	CcSEcCtD
Venlafaxine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000788	0.00128	CcSEcCtD
Venlafaxine—Constipation—Lisinopril—dilated cardiomyopathy	0.000781	0.00127	CcSEcCtD
Venlafaxine—Pain—Lisinopril—dilated cardiomyopathy	0.000781	0.00127	CcSEcCtD
Venlafaxine—Vomiting—Furosemide—dilated cardiomyopathy	0.000774	0.00125	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00077	0.0146	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00077	0.0146	CbGpPWpGaD
Venlafaxine—Rash—Furosemide—dilated cardiomyopathy	0.000768	0.00124	CcSEcCtD
Venlafaxine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000767	0.00124	CcSEcCtD
Venlafaxine—Headache—Furosemide—dilated cardiomyopathy	0.000763	0.00124	CcSEcCtD
Venlafaxine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000753	0.00122	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000747	0.00121	CcSEcCtD
Venlafaxine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000726	0.00118	CcSEcCtD
Venlafaxine—Nausea—Furosemide—dilated cardiomyopathy	0.000723	0.00117	CcSEcCtD
Venlafaxine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000722	0.00117	CcSEcCtD
Venlafaxine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000722	0.00117	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000716	0.0136	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000714	0.0136	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000702	0.0133	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—AGT—dilated cardiomyopathy	0.000692	0.0132	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000673	0.00109	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000664	0.0126	CbGpPWpGaD
Venlafaxine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000656	0.00106	CcSEcCtD
Venlafaxine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000646	0.00105	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000643	0.0122	CbGpPWpGaD
Venlafaxine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000625	0.00101	CcSEcCtD
Venlafaxine—SLC6A3—Monoamine Transport—AGT—dilated cardiomyopathy	0.000613	0.0117	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000612	0.0116	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000612	0.0116	CbGpPWpGaD
Venlafaxine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000604	0.000978	CcSEcCtD
Venlafaxine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000581	0.000941	CcSEcCtD
Venlafaxine—Rash—Lisinopril—dilated cardiomyopathy	0.000576	0.000933	CcSEcCtD
Venlafaxine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000576	0.000932	CcSEcCtD
Venlafaxine—Headache—Lisinopril—dilated cardiomyopathy	0.000572	0.000927	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000569	0.0108	CbGpPWpGaD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000562	0.0107	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000551	0.0105	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000549	0.0104	CbGpPWpGaD
Venlafaxine—Nausea—Lisinopril—dilated cardiomyopathy	0.000543	0.000879	CcSEcCtD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000521	0.00991	CbGpPWpGaD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000517	0.00983	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000494	0.00939	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000471	0.00895	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000466	0.00886	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000466	0.00886	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000446	0.00849	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000443	0.00842	CbGpPWpGaD
Venlafaxine—ABCB1—heart—dilated cardiomyopathy	0.000439	0.0171	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000433	0.00824	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000432	0.00821	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00042	0.00798	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000416	0.00792	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000392	0.00746	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—TNF—dilated cardiomyopathy	0.000365	0.00693	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000358	0.00681	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000345	0.00656	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00034	0.00646	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000331	0.0063	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000331	0.00629	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—dilated cardiomyopathy	0.000314	0.00596	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000311	0.00592	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—dilated cardiomyopathy	0.000278	0.00528	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00027	0.00513	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000263	0.00501	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000263	0.00501	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000252	0.0048	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00025	0.00475	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000249	0.00474	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000245	0.00466	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000239	0.00455	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000239	0.00455	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000237	0.00451	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000231	0.0044	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000227	0.00432	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000225	0.00428	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000225	0.00428	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000222	0.00423	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000215	0.00409	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.00021	0.004	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000209	0.00398	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000205	0.0039	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000203	0.00385	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000199	0.00379	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000199	0.00379	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000197	0.00375	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000192	0.00365	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000188	0.00358	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000185	0.00353	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000184	0.0035	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000183	0.00349	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000183	0.00349	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000176	0.00335	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000174	0.00332	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00017	0.00324	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000164	0.00311	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000159	0.00303	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000158	0.003	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000154	0.00293	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000149	0.00284	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000145	0.00276	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000143	0.00271	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000141	0.00269	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000141	0.00269	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000141	0.00267	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000135	0.00258	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000132	0.00251	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000131	0.0025	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000129	0.00246	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000127	0.00242	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000124	0.00236	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000116	0.00222	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000109	0.00207	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	0.000105	0.002	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000103	0.00196	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000103	0.00195	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000102	0.00194	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.91e-05	0.00189	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.91e-05	0.00189	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	9.82e-05	0.00187	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.22e-05	0.00175	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	9.08e-05	0.00173	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.98e-05	0.00171	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.86e-05	0.00168	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	8.54e-05	0.00162	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.08e-05	0.00154	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RAC1—dilated cardiomyopathy	8e-05	0.00152	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	7.79e-05	0.00148	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	7.72e-05	0.00147	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AGT—dilated cardiomyopathy	7.64e-05	0.00145	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.64e-05	0.00145	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—RAF1—dilated cardiomyopathy	7.52e-05	0.00143	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	6.86e-05	0.00131	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	6.7e-05	0.00127	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	6.7e-05	0.00127	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	6.45e-05	0.00123	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	6.31e-05	0.0012	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	6.3e-05	0.0012	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	6.26e-05	0.00119	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.16e-05	0.00117	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	5.94e-05	0.00113	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	5.88e-05	0.00112	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	5.84e-05	0.00111	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	5.7e-05	0.00108	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	5.37e-05	0.00102	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	5.32e-05	0.00101	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RAF1—dilated cardiomyopathy	5.31e-05	0.00101	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.06e-05	0.000963	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.57e-05	0.000868	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.13e-05	0.000785	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.04e-05	0.000769	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.88e-05	0.000738	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.72e-05	0.000707	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—dilated cardiomyopathy	3.64e-05	0.000692	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.56e-05	0.000677	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.51e-05	0.000667	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.47e-05	0.00066	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.47e-05	0.000659	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.31e-05	0.000629	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.25e-05	0.000617	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.16e-05	0.000601	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.12e-05	0.000594	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.86e-05	0.000544	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.85e-05	0.000541	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.79e-05	0.00053	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.51e-05	0.000477	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	2.1e-05	0.000399	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	2.04e-05	0.000389	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.01e-05	0.000382	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.84e-05	0.00035	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.59e-05	0.000301	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	0.000294	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.54e-05	0.000294	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.51e-05	0.000287	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.46e-05	0.000277	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.45e-05	0.000275	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.42e-05	0.00027	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.41e-05	0.000268	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.39e-05	0.000264	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	0.000258	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.28e-05	0.000243	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.27e-05	0.000241	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	9.53e-06	0.000181	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	9.28e-06	0.000177	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	8.36e-06	0.000159	CbGpPWpGaD
